Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.

Ni HF, Chen JF, Zhang MH, Pan MM, Zhang JD, Liu H, Tang RN, Ma KL, Liu BC.

Ren Fail. 2013 Aug;35(7):996-1004. doi: 10.3109/0886022X.2013.809006. Epub 2013 Jul 12.

PMID:
23848241
2.

Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.

Schaier M, Vorwalder S, Sommerer C, Dikow R, Hug F, Gross ML, Waldherr R, Zeier M.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F769-80. doi: 10.1152/ajprenal.90530.2008. Epub 2009 Jun 17.

3.

The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.

Krämer S, Binder E, Loof T, Wang-Rosenke Y, Martini S, Khadzhynov D, Budde K, Neumayer HH, Peters H.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F218-27. doi: 10.1152/ajprenal.90617.2008. Epub 2009 May 13.

4.

FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.

Xu M, Liu D, Ding LH, Ma KL, Wu M, Lv LL, Wen Y, Liu H, Tang RN, Liu BC.

Acta Pharmacol Sin. 2014 Dec;35(12):1537-45. doi: 10.1038/aps.2014.100. Epub 2014 Nov 17.

5.

Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.

Peters H, Martini S, Wang Y, Shimizu F, Kawachi H, Krämer S, Neumayer HH.

Kidney Int. 2004 Oct;66(4):1434-43.

6.

FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.

Ni H, Chen J, Pan M, Zhang M, Zhang J, Chen P, Liu B.

J Mol Histol. 2013 Dec;44(6):693-703. doi: 10.1007/s10735-013-9521-8. Epub 2013 Aug 2.

PMID:
23907620
7.

Effect of FTY720 on chronic cyclosporine nephropathy in rats.

Kim JY, Lim SW, Li C, Kim JS, Ahn KO, Yang HJ, Choi BS, Kim YS, Kim J, Bang BK, Yang CW.

Transplantation. 2005 Nov 15;80(9):1323-30.

PMID:
16314802
8.

Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.

Huang YR, Wei QX, Wan YG, Sun W, Mao ZM, Chen HL, Meng XJ, Shi XM, Tu Y, Zhu Q.

J Ethnopharmacol. 2014 Sep 29;155(3):1541-52. doi: 10.1016/j.jep.2014.07.048. Epub 2014 Aug 1.

PMID:
25087615
9.

FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.

Delbridge MS, Shrestha BM, Raftery AT, El Nahas AM, Haylor J.

Transplant Proc. 2007 Dec;39(10):2992-6.

PMID:
18089307
10.

Treatment with the immunomodulator FTY720 (fingolimod) significantly reduces renal inflammation in murine unilateral ureteral obstruction.

Thangada S, Shapiro LH, Silva C, Yamase H, Hla T, Ferrer FA.

J Urol. 2014 May;191(5 Suppl):1508-16. doi: 10.1016/j.juro.2013.10.072. Epub 2014 Mar 26.

PMID:
24679864
11.

Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rats?

Liu WH, Tang NN, Zhang QD.

Chin Med J (Engl). 2009 Jan 20;122(2):199-204.

PMID:
19187647
12.

[Effect of FTY720 on glomerulosclerosis and expression of cell cycle regulatory proteins in subtotally nephrectomized rats].

Zhu GQ, Zhou JH, Xie M, Hao Y.

Zhonghua Er Ke Za Zhi. 2007 Dec;45(12):922-6. Chinese.

PMID:
18339282
13.

Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney.

An WS, Kim HJ, Cho KH, Vaziri ND.

Am J Physiol Renal Physiol. 2009 Oct;297(4):F895-903. doi: 10.1152/ajprenal.00217.2009. Epub 2009 Aug 5.

14.

N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.

Wang M, Liu R, Jia X, Mu S, Xie R.

Int J Mol Med. 2010 Dec;26(6):795-801.

PMID:
21042772
15.

Citrate attenuates tubulointerstitial fibrosis in 5/6 nephrectomized rats by decreasing transforming growth factor-beta1.

Manotham K, Eiam-Ong S, Eiam-Ong S, Wannakrairot P, Praditpornsilpa K, Chusil S, Tungsanga K.

J Med Assoc Thai. 2006 Aug;89 Suppl 2:S168-77.

PMID:
17044470
16.

Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury.

Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK.

Nephrol Dial Transplant. 2008 Mar;23(3):842-52. Epub 2007 Nov 5.

PMID:
17984109
17.

Effects of tacrolimus and dexamethasone on tubulointerstitial fibrosis in mercuric chloride treated Brown Norway rats.

Suzuki K, Kanabayashi T, Nakayama H, Doi K.

Exp Toxicol Pathol. 2003 Sep;55(2-3):197-207.

PMID:
14620542
18.

Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies.

Yang T, Vesey DA, Johnson DW, Wei MQ, Gobe GC.

Transl Res. 2007 Jul;150(1):40-50. Epub 2007 May 23.

PMID:
17585862
19.

Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure.

Therrien FJ, Agharazii M, Lebel M, Larivière R.

Am J Nephrol. 2012;36(2):151-61. doi: 10.1159/000340033. Epub 2012 Jul 19.

PMID:
22813949
20.

Inhibition of TGF-β1/Smad signal pathway is involved in the effect of Cordyceps sinensis against renal fibrosis in 5/6 nephrectomy rats.

Pan MM, Zhang MH, Ni HF, Chen JF, Xu M, Phillips AO, Liu BC.

Food Chem Toxicol. 2013 Aug;58:487-94. doi: 10.1016/j.fct.2013.04.037. Epub 2013 Apr 26.

PMID:
23624380

Supplemental Content

Support Center